ptxâ®

  1. T

    Angiotech Announces That Cook Medical's Zilver® Ptx® Drug-Eluting Stent Meets Its Pri

    Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) announced that a summary of the final clinical trial results for the randomized study of Cook Medical's Zilver® PTX® Drug-Eluting Peripheral Stent for use in patients with peripheral arterial disease (PAD) in the superficial femoral artery...
Back
Top